MedTrace Logo

Genetic Testing in Detection of Late-Onset Hearing Loss

NCT00511381 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3681

Last updated 2012-03-01

No results posted yet for this study

Summary

Two major limitations of existing audiometric newborn hearing screening programs are their inability to detect forms of deafness that are not expressed at birth and the low compliance with obtaining recommended audiologic confirmation and/or follow-up. Molecular genetic tests on blood spots from all newborns will identify those at risk for the most frequent causes of late-onset hearing loss and to add these infants to the group who should receive continued audiologic monitoring.

Conditions

Interventions

GENETIC

No intervention

No intervention

Sponsors & Collaborators

  • Pediatrix

    lead OTHER

Principal Investigators

  • Gail Lim, ARNP · Pediatrix

  • Zhili Lin, MD, PhD · Pediatrix Screening

  • Reese H Clark, MD · Pediatrix

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511381 on ClinicalTrials.gov